You do not currently have access to this content.
Cancer Res (2025) 85 (8_Supplement_2): ND11.
Abstract. Molecular glue degrader (MGD) is an emerging therapeutic strategy offering an exciting alternative to traditional small molecules exploring new target space. These small molecules interact ...
The Chimeric Antigen Receptor (CAR) T cell therapy has emerged as a ground-breaking immunotherapeutic approach in cancer treatment and demonstrated encouraging clinical results in autoimmune disease ...
Search for other works by this author on: ...
Johns Hopkins University School of Medicine, Baltimore, MD.
At today’s Senate Health, Education, Labor, and Pensions Committee hearing, nominee for Secretary of the Department of Health and Human Services Robert F. Kennedy (RFK) Jr. refused to renounce his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results